You have free access to this content

Clinical Liver Disease

Cover image for Vol. 6 Issue 2

Edited By: Michael Lucey, MD

Online ISSN: 2046-2484

Associated Title(s): Hepatology, Liver Transplantation

Recently Published Issues

See all

  • Current Issue:August 2015

    Volume 6, Issue 2

    Special Issue: Editorial, Palliative Care & Non-Vi...

  • July 2015

    Volume 6, Issue 1

    Special Issue: The Future in Liver Medicine & Pall...

  • June 2015

    Volume 5, Issue 6

    Special Issue: The Future in Liver Medicine, Liver...

  • May 2015

    Volume 5, Issue 5

    Special Issue: Hepatic Encephalopathy & Liver Tran...

  • April 2015

    Volume 5, Issue 4

    Special Issue: Liver and the Microbiome & Liver Tr...

Palliative Care

Guest Edited by Anne Larson, M.D. F.A.C.P. A.G.A.F.

NEW in Palliative Care:

Overview of Palliative Care and Hospice Services
Sara E. Wordingham, M.D. and Keith M. Swetz, M.D., M.A.
End-stage chronic liver disease (ESLD) affects thousands of Americans. Up to 10% of eligible patients will die without undergoing transplantation, and those who await transplantation may have high symptom burden, making palliative care consultation for those patients an important tool to improve quality of life.
Read the full textWatch the author interview.Listen to the article presentation

Issues in the End-Stage Liver Disease Patient for Which Palliative Care Could Be Helpful
Paula Cox-North, Ph.D., A.R.N.P.
ESLD is often associated with multiple complications including ascites, hepatic encephalopathy, pain, and pruritus. Learn how to approach the meticulous management required.
Read the full textWatch the author interview.Listen to the article presentation

Working With Palliative Care Services
Amanda J. Brisebois M.Sc., M.D., and Puneeta Tandon M.D.
While palliative care is often perceived as synonymous with the active process of dying, it is not only end of life care. All types of practitioners can provide palliative services, and palliative care principles and specialists can be helpful in a variety of clinical situations.
Read the full textWatch the author interview.Listen to the article presentation

More on Palliative Care:

Overall Health-Related Quality of Life in Patients With End-Stage Liver Disease
Zobair Younossi, M.D., M.P.H., and Linda Henry Ph.D.
Read the full textWatch the author interview.Listen to the article presentationAnswer questions and earn CME

A ‘‘Good Death’’ With Irreversible Liver Disease: Talking With Patients and Families About Deteriorating Health and Dying
Kirsty Boyd, M.B.Ch.B.(Hon.), F.R.C.P. (Edin.), M.Med.Sci., Barbara Kimbell, Ph.D., Scott Murray, M.B.Ch.B., D.C.H., M.R.C.G.P., M.D., F.R.C.G.P., F.R.C.P.Ed., John Iredale D.M., F.R.C.P., F.Med.Sci., F.R.S.E.
Read the full textWatch the author interview.Listen to the article presentationAnswer questions and earn CME

Palliative Care for Patients with End-Stage Liver Disease: An Overview
Mina O. Rakoski, M.D., M.Sc. and Michael L. Volk, M.D., M.Sc., AGAF
Read the full textWatch the author interview.Listen to the article presentationAnswer questions and earn CME

Palliative Care for Patients With End-Stage Liver Disease: The Role of the Liver Team
Sean G. Kelly, M.D. and John P. Rice, M.D.
Read the full textWatch the author interview.Listen to the article presentation

Is Palliative Care Appropriate in the Liver Transplant Candidate?
Rohit Pai M.D., Constantine J. Karvellas M.D., S.M.
Read the full textWatch the author interview.Listen to the article presentationAnswer questions and earn CME


Liver and the Microbiome
Guest Edited by Eamonn M.M. Quigley, MD, FRCP, FACP, FACG, FRCPI

Host-Microbiome Interactions in Health and Disease
Liam O’Mahony, PhD

Read the full textWatch the author interview.Listen to the article presentationAnswer questions and earn CME

Microbiome-Immune Interactions and Liver Disease
James H. Tabibian MD, PhD, Cyril Varghese MD, Steven P. O’Hara PhD, and Nicholas F. LaRusso MD
Read the full textWatch the author interview.Listen to the article presentationAnswer questions and earn CME

The Gut Microbiome: What Do We Know?
Francisco Guarner, MD, PhD
Read the full textListen to the article presentationAnswer questions and earn CME

The Metabolic Role of the Microbiota
Wiley Barton B.Sc. Fergus Shanahan MD, Paul D. Cotter PhD, Orla O’Sullivan PhD
Read the full textListen to the article presentationAnswer questions and earn CME

Is the Gut Microbiota Disturbed in Chronic Liver Disease?
Eamonn M.M. Quigley, MD, FRCP, FACP, FACG, FRCPI
Read the full textListen to the article presentation

Microbiome and Complications of Liver Disease
Jasmohan S. Bajaj, MD, MS, FACG, AGAF
Read the full textWatch the author interview.Listen to the article presentationAnswer questions and earn CME

iTunes logo

Access CLD on the go.
Listen to the author interviews and readings of the full articles by subscribing to the iTunes podcast.



Check out what's new in CLD's sister journal, HEPATOLOGY

HEPATOLOGY Highlights



New Editorial Series: In My Opinion

John P. Rice

Hepatitis C Treatment:
Back to the Warehouse

John P. Rice, M.D
Read the full textListen to the article presentation






Popular in CLD's series on Hepatitis C:
Guest Edited by Donald M. Jensen, MD, FACP

New Therapies for Hepatitis C: Latin American Perspectives
Rafael Claudino Botero, MD, FACP, and Martin Tagle, MD
Watch the interview
Learn about the unique challenges for treating Hepatitis C in Latin America, including a detailed country by country analysis.
Read the full textWatch the author interview.Listen to the article presentationAnswer questions and earn CME

Prefer to learn in Spanish? Read the article or watch an interview with Dr. Botero, todo en español!

Los Nuevos Tratamiento de Hepatitis C: Perspectivas Latinoamericanas
Read the full textWatch the author interview.

Non-viral Liver Infections

Guest Edited by Emily A. Blumberg, M.D.

Amebic Liver Abscess
Judith A. Anesi M.D., and Stephen Gluckman M.D.
Ultrasound image of an amebic liver abscess.
Amebic liver abscesses are caused by Entamoeba histolytica, a protozoan parasite that is acquired via ingestion of food or water contaminated by human feces. While generally asymptomatic, it can cause amebic dysentery or even extraintestinal disease. Learn the epidemiology, clinical manifestations, diagnosis, and management.
Read the full textListen to the article presentationAnswer questions and earn CME

Recognizing Clonorchiasis: A Foodborne Illness Leading to Significant Hepatobiliary Disease
Charitha Gowda, M.D., M.P.H.
Clonorchiasis, known as the Oriental liver fluke, is implicated in a wide spectrum of hepatobiliary disease ranging from asymptomatic infection to more severe liver disease including cholangitis or portal hypertension. Learn how to recognize the signs.
Read the full textWatch the author interview.Listen to the article presentationAnswer questions and earn CME

Hepatosplenic Candidiasis
Oliver A. Cornely M.D., Christopher Bangard M.D., and Natalie I. Jaspers M.D.
Hepatosplenic candidiasis is a very rare disease, but is the most frequent form of chronic disseminated candidiasis. Learn how to recognize the signs and symptoms.
Read the full textWatch the author interview.Listen to the article presentationAnswer questions and earn CME

Pyogenic Liver Abscess
Sarah Longworth M.D. and Jennifer Han M.D., M.S.C.E.
Pyogenic liver abscess (PLA) is a rare disease. Although once uniformly fatal, advances in imaging modalities and antimicrobial therapy have led to significant improvements in outcomes.
Read the full textListen to the article presentationAnswer questions and earn CME


The Future in Liver Medicine

Guest Edited by Meena Bansal, MD

Liver Fibrosis: Therapeutic Armory 40 Years On
John P. Iredale, FRCP, F Med Sci, FRSE, and Antonella Pellicoro, PhD
Read the full textWatch the author interview.Listen to the article presentation

Histologic and Noninvasive Estimates of Liver Fibrosis
Pierre Bedossa, M.D., Ph.D., Keyur Patel, M.D., and Laurent Castera, M.D., Ph.D.

Read the full textWatch the author interview.Listen to the article presentationAnswer questions and earn CME

The Future of Hepatology: Embrace Change
Scott L. Friedman MD and Yael L. Friedman MA
Interview with Scott Friedman
Read the full textWatch the author interview.Listen to the article presentationAnswer questions and earn CME

Training the Next Generation of Hepatologist: What Will They Need to Know?
Dina L. Halegoua-De Marzio MD, and Steven K. Herrine MD
Read the full textWatch the author interview.Listen to the article presentationAnswer questions and earn CME

Personalized Management of Hepatocellular Carcinoma Based on Molecular Information: Future Prospects
Nicolas Goossens, MD, MSc Yujin Hoshida, MD, PhD
Read the full textWatch the author interview.Listen to the article presentationAnswer questions and earn CME

Increasing Impact of Drug-Induced Liver Injury
Paul H. Hayashi, MD, MPH and Naga P. Chalasani MD
Read the full textWatch the author interview.Listen to the article presentationAnswer questions and earn CME

Future Watch: Evolving Trends in the Management of Nonalcoholic Steatohepatitis
Arun J. Sanyal, MBBS, MD
Read the full textWatch the author interview.Listen to the article presentationAnswer questions and earn CME


AASLD

SEARCH

SEARCH BY CITATION